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LAIR-1, a Novel Inhibitory Receptor
Expressed on Human Mononuclear Leukocytes
Linde Meyaard,* Gosse J. Adema,*³ Chiwen Chang,* led to the identification of inhibitory receptors present
on NK cells that bind MHC expressed on the target cell.Erica Woollatt,² Grant R. Sutherland,²
Lewis L. Lanier,* and Joseph H. Phillips* In humans, two separate families of inhibitory receptors
have been identified on NK cells: killer cell inhibitory*Departments of Immunobiology and
Molecular Biology receptors (KIRs), which are immunoglobulin superfamily
members (Colonna and Samaridis, 1995; D'Andrea etDNAX Research Institute of Molecular and
Cellular Biology al., 1995; Wagtmann et al., 1995; Lanier and Phillips,
1996), and the CD94/NKG2 receptors of the C-type lec-901 California Avenue
Palo Alto, California 94304-1104 tin superfamily (Lazetic et al., 1996; Phillips et al., 1996;
Sivori et al., 1996). All of these inhibitory receptors pos-²Centre for Medical Genetics
Department of Cytogenetics and Molecular sess cytoplasmic tails with immune receptor tyrosine-
based inhibitory motifs (ITIMs) (Thomas, 1995). UponGenetics
Women's and Children's Hospital phosphorylation, cytoplasmic ITIMs bind the SH2 do-
mains of certain phosphatases, leading to down-regula-Adelaide, South Australia, 5006
Australia tion of cell activation (Scharenberg and Kinet, 1996).
To identify molecules important in the regulation of
NK cell cytotoxicity, we immunized mice with human
NK cells and screened for MAbs that were capable ofSummary
inhibiting NK cell mediated cytotoxicity. A MAb, desig-
nated DX26, that when cross-linked delivered a negativeIn the present study, we describe a novel inhibitory
signal to NK cells, was identified. The antigen recog-receptor, leukocyte-associated immunoglobulin-like
nized by DX26 MAb (designated leukocyte- associatedreceptor-1 (LAIR-1), that is constitutively expressed on
immunoglobulin-like receptor-1 [LAIR-1]) is a memberthe majority of human peripheral blood mononuclear
of the immunoglobulin superfamily, with homology toleukocytes. LAIR-1 is a 32 kDa transmembrane glyco-
KIRs, and possesses two ITIMs in its cytoplasmic do-protein with a single immunoglobulin-like domain and
main. LAIR-1, however, does not appear to recognizea cytoplasmic tail containing two immune receptor
class I human leukocyte antigens (HLA) and thus repre-tyrosine-based inhibitory motifs. LAIR-1 recruits SHP-1
sents a novel (HLA-independent) inhibitory moleculeand SHP-2 phosphatases upon activation, and cross-
that may play an important role in the regulation of NKlinking of the LAIR-1 antigen on natural killer (NK) cells
cell function.results in strong inhibition of NK cell±mediated cyto-
toxicity. Although it is structurally related to human
killer cell inhibitory receptors, LAIR-1 does not appear Results
to recognize human leukocyte antigen (HLA) class I
molecules and thus represents a novel HLA class I± DX26 Identifies an Inhibitory Receptor
independent mechanism of NK cell regulation. on NK Cells
To identify molecules that are involved in negative sig-
Introduction naling, mice were immunized with a human NK cell clone
and antibodieswere screened for their capacity to inhibit
Natural killer (NK) cells are a subpopulation of lympho- NK cell±mediated lysis of Fc-receptor (FcR)±bearing tar-
cytes distinct from T and B cells. NK cells are capable gets. A MAb, designated DX26, was isolated that effi-
of lysing transformed and virus-infected cells without ciently inhibited the NK cell±mediated cytotoxicity of
apparent presensitization, and are considered important the human FcgRII (CD32) transfected Epstein-Barr virus
cellular components of innate immunity (reviewed by (EBV)±transformed B cell line, 721.221/CD32 (Figure 1).
Trinchieri, 1989). The molecular interactions that trigger Cytolysis of the FcR-negative parent line, 721.221, how-
the cytolytic functions of NK cells are not completely ever, was not affected by DX26 MAb, indicating that
understood. Monoclonal antibodies (MAbs) recognizing FcR cross-linking of LAIR-1 (the antigen recognized by
adhesion and signaling molecules, however, have been DX26 MAb) was required to deliver the negative signal
shown to induce NK cell±mediated cytotoxicity in vitro (Figure 1). Further evidence for the inhibitory signal±
(Siliciano et al., 1985; Lanier et al., 1988b; Moretta et transducing capabilities of LAIR-1 was obtained using
al., 1991; Shibuya et al., 1996). the FcR-expressing mouse mastocytoma cell line, P815.
In recent years, progress has been made in under- Many NK cell clones lyse P815 in the presence of MAbs
standing the receptors responsible for inhibiting NK cell against positive signal molecules, such as CD2, CD16,
functions. The early observation that NK cells selectively CD69, and DNAM-1 (Lanier et al., 1997). Antibody-medi-
kill targets that lack major histocompatibility complex ated NK cell lysis of P815 was also inhibited by DX26
(MHC) on their surface (Karre et al., 1986), eventually MAb, indicating that cross-linking of LAIR-1 led to inhibi-
tion of cytotoxicity, even in the presence of strong posi-
tive signals (Figure 2).³Present address: University Hospital Nijmegen St. Radboud, De-
Since the majority of resting NK cells express LAIR-1,partment of Tumor Immunology, 6525 EX Nijmegen, The Nether-
lands. experiments were undertaken to determine whether
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B cells (80%±90%), and CD32CD141 monocytes (99%±
100%) (Figures 4A±4C). LAIR-1, however, was not ex-
pressed on peripheral blood granulocytes, platelets, or
red blood cells (data not shown). The majority of human
fetal thymocytes, also expressed LAIR-1 (Figure 4D), as
well as all NK cell and T cell clones and all T cell tumor
cell lines (Table 1). The long-term cultured NK lines,
NKL and NK92, were negative for LAIR-1, as were EBV-
transformed B cell lines, the B cell tumor Daudi, the NK-
like tumor cell line YT, and several nonhematopoietic
cell lines (Table 1).
Figure 1. DX26 MAb Inhibits NK Cell Cytotoxicity When Cross-
Linked by FcR on the Target Cell
NK clone KS279.p1 was assayed for lysis of 721.221 target cells or cDNA Cloning of LAIR-1
721.221 transfectants expressing the human FcgRII (721/CD32) in To identify a LAIR-1±encoding cDNA, 293T cells were
the presence of DX26 MAb or control IgG1. DX26 MAb and control
transfected with a cDNA library prepared from a poly-IgG1 were used at 10 mg/ml. Data are representative of experiments
clonal human NK cell line (Lanier et al., 1994), and ex-performed with several NK cell clones.
pression cloning using flow cytometry was performed.
As shown in Figure 5A, a single cDNA that encoded a
protein recognized by the DX26 MAb was obtained. TheLAIR-1 functions as an inhibitory receptor on freshly
isolated NK cells. Resting NK cells were purified from LAIR-1 cDNA was 1728 bp, containing an 864 bp open
reading frame encoding a type I membrane protein withperipheral blood to greater than 90% purity and assayed
for cytolysis of anti-CD16 MAb±coated P815 in the pres- a 21 amino acid (aa) leader sequence, a 142 aa extracel-
lular domain, a 23 aa transmembrane domain, and a 101ence or absence of DX26 MAb. As was observed with
NK cell clones, freshly isolated NK cell cytolysis of aa cytoplasmic region (Figures 5B and 5C). One pair of
cysteines in the extracellular domain generates a singleanti-CD16 coated P815 was significantly inhibited by
the presence of DX26 MAb (Figure 3A). Cytolysis of the immunoglobulin-like domain, thus classifying LAIR-1 as
a member of the immunoglobulin superfamily. The extra-NK-sensitive tumor cell line K562 by NK cells in freshly
isolated peripheral blood mononuclear cells (PBMCs) cellular domain had one potential N-linked glycosylation
site. The predicted molecular weight of the LAIR-1 poly-was also inhibited by DX26 MAb (Figure 3B). DX26
F(ab)92 fragments did not affect killing of K562, which peptide is 32 kDa. The cytoplasmic domain contained
the amino acid sequences VTYAQL and ITYAAV, spacedfurther substantiates the necessity for LAIR-1 to be
cross-linked in order to generate a negative signal in by 24 aa, which fit the consensus sequences for ITIMs
(V/IxYxxxL/V) (D'Ambrosio et al., 1995).UsingfluorescenceNK cells. Likewise, NK cell cytotoxicity against a panel
of FcR-negative tumor cells was unaffected by the pres- in situ hybridization, the LAIR-1 gene was mapped tochro-
mosome 19q13.4.ence of the DX26 MAb (data not shown).
Northern blot analysis of PBMCs showed two pre-
dominant transcripts of approximately 1.7 and 3 kbLAIR-1 Is a Broadly Expressed Leukocyte Antigen
Phenotypic analysis of human peripheral blood lympho- (Figure 6). Transcripts were found in human monocytes,
Jurkat, U937, and human NK cell clones, but not in LAIR-cytes demonstrated that LAIR-1 is a widely expressed
molecule on peripheral blood leukocytes. LAIR-1 is negative cell lines, such as the EBV-transformed B cell
line JY (Figure 6). Southern blot analysis of human geno-prominently expressed on normal peripheral blood
CD31CD41 T cells (70%±80%), CD31CD81 T cells (80%± mic DNA demonstrated a relatively simple hybridization
pattern for LAIR-1 (data not shown). This uncomplicated90%), CD32CD561 NK cells (95%±100%), CD32CD191
Figure 2. DX26 MAb Inhibits NK Cell Cyto-
toxicity in the Presence of Cross-Linking MAb
to Positive Signaling Structures
NK clone KS279.p1 was assayed for lysis of
P815 target cells, when stimulated with 5 mg/
ml MAb against CD16 (A), CD2 (B), CD69 (C),
or DNAM-1 (D) in the presence of DX26 MAb
or control IgG1. DX26 MAb and control IgG1
were used at 10 mg/ml. Data are representa-
tive of experiments performed with several
NK cell clones.
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Figure 3. DX26 MAb Inhibits Cytolytic Function of Resting NK Cells
(A) NK cells were purified from human peripheral blood and assayed
for lysis of P815 cells when stimulated with 5 mg/ml anti-CD16 in
the presence of 10 mg/ml control IgG1 or DX26 MAb. Data are
representative of three independent experiments with cells from
different donors.
(B) Freshly isolated PBMCs were used as effector cells and assayed
for spontaneous killing of K562 cells in the presence of 10 mg/
ml control IgG1, DX26 MAb, or DX26 F(ab)92 fragments. Data are
representative of experiments with cells from four different donors.
Figure 4. LAIR-1 Expression on Peripheral Blood Leukocytes and
genomic organization suggests that the LAIR-1 probe Fetal Thymocytes
hybridizes with a single or relatively few genes. (A±C) PBMCs were stained with DX26 MAb and visualized by phy-
coerythrin (PE)±conjugated goat-anti mouse-IgG; CyChrome-conju-
gated CD3 MAb; and fluorescein isothiocyanate (FITC)±conjugatedBiochemistry of LAIR-1
CD4, CD8, CD56, CD19, or CD14 MAb. Cells were analyzed on aTo study the biochemical features of LAIR-1, the protein
FACScan and gated for CD31 lymphocytes (A), CD32 lymphocyteswas immunoprecipitated with DX26 MAb from 125I-
(B), or monocytes (C) on the basisof forward and side scatter profiles
labeled lysates of 293T cells transfected with the LAIR-1 and anti-CD3 MAb staining.
cDNA and two peripheral blood human NK cell clones. (D) Human fetal thymocytes were stained with DX26 MAb visualized
LAIR-1 precipitated from LAIR-1± transfected cells was by PE-conjugated goat anti-mouse IgG and CyChrome-conjugated
anti-CD3 MAb.a z40 kDa monomer when analyzed by SDS±poly-
Markers were set using appropriate isotype control antibodies. Dataacrylamide gel electrophoresis (SDS-PAGE) under both
are representative of three independent experiments.nonreducing and reducing conditions (Figure 7). The
mobility of LAIR-1 decreased from z40 to z32 kDa after
treatment with N-glycosidase F, in agreement with the
(O'Shea et al., 1992), lysed, and immunoprecipitatedpredicted protein size and one N-linked glycosylation
with DX26 MAb. Immunoprecipitates were then ana-site (Figure7). Immunoprecipitation with DX26 MAb from
lyzed by Western blot using antibodies specific forlysates of two human NK cell clones revealed, in addition
SHP-1 and SHP-2. As shown in Figure 8, bothSHP-1 andto LAIR-1 at 40 kDa, a smaller protein migrating at z32
SHP-2 associated with tyrosine-phosphorylated LAIR-1.kDa (Figure 7). This smaller protein also decreased in
These results suggest that recruitment of SHP-1 andsize after deglycosylation. Whether this represents a
SHP-2 may be involved in mediating the negative signaldistinct LAIR-1 isoformor a proteolytic cleavageproduct
transduced via engagement of the LAIR-1 molecule.of LAIR-1 is unknown.
LAIR-1 Binds SHP-1 and SHP-2 Discussion
The existence of two consensus sequences for ITIMs
within the cytoplasmic domain of LAIR-1 suggested that Regulation of immune responses is determined by the
balance of positive signals to initiate an immune re-the generation of an inhibitory signal in NK cells was
manifested by the recruitment of SH2-containing tyro- sponse and inhibitory mechanisms to prevent excessive
inflammatory responses and autoimmunity. Here wesine phosphatases-1 and/or -2 (SHP-1 and/or SHP-2).
To determine whether LAIR-1 was capable of binding describe a novel inhibitory receptor, LAIR-1, that may
function to down-regulate immune responses. LAIR-1protein tyrosine phosphatases, a NKcell clone was stim-
ulated with pervanadate (an inhibitor of protein tyrosine is a novel member of the immunoglobulin superfamily
that is expressed on the majority of peripheral bloodphosphatases that induces tyrosine phosphorylation
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mononuclear leukocytes. Cross-linking of LAIR-1 on hu-
man NK cells delivers a potent inhibitory signal that is
capable of inhibiting target cell lysis by both resting and
activated NK cells in vitro.
LAIR-1 isstructurally related toseveral other inhibitory
immunoglobulin superfamily members, including human
KIRs (Colonna and Samaridis, 1995; D'Andrea et al.,
1995; Wagtmann et al., 1995), human FcRa (Maliszewski
et al., 1990), bovine FcgRII (Zhang et al., 1995), mouse
gp49 (Arm et al., 1991; Rojo et al., 1996), and mouse
gp91 or paired immunoglobulin-like receptors (Hayami
et al., 1997; Kubagawa et al., 1997). The overall homol-
ogy of LAIR-1 with these proteins is less than 30%.
LAIR-1, however, shows slightly higher homology (32%)
to members of a recently identified novel group of genes
designated immunoglobulin-like transcripts (ILTs) (Cella
et al., 1997; Samaridis and Colonna, 1997). LAIR-1, KIRs,
ILTs, and FcRa all are localized to the same human
chromosome region, 19q13.4, suggesting that these
molecules evolved from a common ancestral gene.
Consistent with the inhibitory signal given to NK cells,
the cytoplasmic domain of LAIR-1 contains two tyro-
Figure 5. cDNA Cloning of LAIR-1sine-based inhibitory motifs (VTYAQL and ITYAAV). In
the human KIRs, similar ITIMs were found to recruit
phosphatases (primarily SHP-1) upon tyrosine phos-
phorylation and thereby to inhibit positive signal trans- tions with DX26 MAb identified two proteins with slightly
different molecular weights after deglycosylation. Weduction via other receptors (Burshtyn et al., 1996; Camp-
bell et al., 1996; Fry et al., 1996; Olcese et al., 1996; have recently identified, by colony hybridization of a T
cell±derived cDNA library, a putative family member ofScharenberg and Kinet, 1996). Indeed, activation of NK
cells with sodium pervanadate resulted in the binding LAIR-1, which we have designated LAIR-2 (EMBL/Gen-
Bank/DDBJ accession number AF013250). LAIR-2 con-of both SHP-1 and SHP-2 phosphatases to LAIR-1. This
suggests that the binding of these phosphatases to tains one immunoglobulin-like domain, which is 84%
homologous to LAIR-1; however, it lacks both a trans-LAIR-1 might lead to inhibition of downstream molecular
events associated with cellular activation. membrane and a cytoplasmic domain, suggesting that
LAIR-2 is a secreted protein (data not shown). FurtherLAIR-1 may be a member of a novel family of highly
related receptors, similar to the situation with ILTs, gp49, studies are required to delineate the functions of LAIR-2
as well as to define other possible LAIR-1 family members.and KIRs. Northern blot analysis revealed at least two
distinctive mRNA transcripts, and immunoprecipita- We have not yet defined the ligand(s) for LAIR-1. Since
Table 1. Expression of LAIR on Human Tumor Cell Lines
Mean Fluorescence Intensity
Cell Line Type Control IgG1 DX26 MAb
HUT78 T cell tumor ,5 25.8
Peer T cell tumor ,5 29.1
Molt4 T cell tumor ,5 30.7
CEM T cell tumor ,5 92.7
Jurkat T cell tumor ,5 47.1
HL60 Promyeloid tumor ,5 46.9
U937 Myeloid tumor ,5 49.5
721.221 EBV B cell ,5 ,5
JY EBV B cell ,5 ,5
Daudi B cell tumor ,5 ,5
YT NK cell tumor ,5 ,5
NKL NK cell line ,5 ,5
NK92 NK cell line ,5 ,5
Colo205 Colon carcinoma ,5 ,5
293T Embryonic kidney ,5 ,5
PA-1 Teratocarcinoma ,5 ,5
FO-1 Melanoma ,5 ,5
Cells were stained with control IgG1 or DX26 MAb and PE-conjugated goat-anti-mouse-IgG as a second step. Cells were analyzed on a
FACScan. Data are representative of three independent experiments.
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(Figure 5 continued from previous page)
(A) LAIR-1 expression on 293T cells trans-
fected with the pJFE14 vector containing an
irrelevant insert or LAIR-1 cDNA.
(B) Nucleotide and predicted amino acid se-
quences of LAIR-1. The leader sequence and
putative transmembrane domain are under-
lined. The potential N-linked glycosylation
site in the extracellular domain is circled. The
ITIM sequences in the cytoplasmic domain
are indicated by underlining and bold print.
These sequence data are available from
EMBL/GenBank/DDBJ under accession num-
ber AF013249.
(C) Schematic diagram of the LAIR-1 protein.
The diagram indicates leader peptide, extra-
cellular, transmembrane,and cytoplasmic re-
gions and the pair of cysteine residues in the
extracellular domain potentially able to par-
ticipate in intrachain disulfide bonding for the
formation of an immunogloblulin-like domain.
the DX26 MAb does not interfere with HLA class I recog- LAIR-1, or closely related family members, will be found
to provide a mechanism of regulation in a variety ofnition by a large panel of NK clones (data not shown),
it seems unlikely that LAIR-1 recognizes HLA class I immune interactions.
molecules. Furthermore, since LAIR-1 is broadly ex-
Experimental Procedurespressed on the majority of mononuclear leukocytes, its
ligand(s) may demonstrate a more restricted expression.
CellsExperiments are presently underway using LAIR-1 fu-
Peripheral blood from healthy donors was purchased from Stanford
sion proteins to probe various tissues and cell types for Blood Center (Stanford, CA). PBMCs were isolated by Ficoll-
potential ligands for this inhibitory receptor. Hypaque centrifugation. Resting NK cells were purified from PBMCs
At present, we have studied the function of LAIR-1 by magnetic bead depletion as described (Phillips et al., 1992).
NK clones were established as described (Phillips et al., 1991)only on peripheral blood NK cells. DX26 MAb also stains
and maintained in culture using the method of Yssel et al. (1984).peripheral blood B cells, T cells, and monocytes as well
The HLA class I±deficient EBV-transformed lymphoblastoid cellas the majority of thymocytes. The functional signifi- line 721.221 has been described (Shimizu andDeMars, 1989). DT287
cance of the molecules recognized by DX26 MAb on is a stable transfectant of 721.221, expressing human FcgRII (CD32),
these other mononuclear leukocytes remains to be de- generated in our laboratory. 293 cells expressing SV40 large T anti-
gen (293T) were generously provided by T. Kitamura (DNAX). P815,termined. However, it is reasonable to predict that
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Figure 6. Expression of LAIR-1 mRNA
Total RNA of human monocytes (lane 1), Jurkat (lane 2), U937 (lane Figure 7. LAIR-1 Is a 32 kDa Protein Expressed as a Monomer
3), JY (lane 4), and two different human NK cell clones (lanes 5 and 125I-labeled labeled 293T cells, transfected with the LAIR-1 encoding
6) was analyzed for LAIR transcripts using a 32P-labeled LAIR-1 cDNA (lane 3 and 4) and two different human NK cell clones (lanes
probe (top). As a control for the amount of RNA in each lane, hybrid- 1, 2, 5, and 6) were lysed, and LAIR-1 antigen was immunoprecipi-
ization with a b-actin probe of the same blot is also shown (bottom). tated with DX26 MAb. The immunoprecipitates were treated with
N-glycosidase where indicated and analyzed by SDS-PAGE under
nonreducing conditions. Analysis under reducing conditions re-
sulted in an identical migration of the proteins (data not shown).HUT78, Peer, Molt4, CEM, Jurkat, HL60, U937, JY, Daudi, Colo205,
PA-1, and K562 were obtained from the American Type Culture
Collection (Rockville, MD). YT-2C2 is a NK-like tumor cell line that
was kindly provided by K. Smith (Yodoi et al., 1985). FO-1 is a human probe in Northern and Southern blot analyses. Total RNA was iso-
melanoma cell line that was a kind gift of S. Ferrone (D'Urso et al., lated with RNA-STAT-60 (Teltest `B', Friendswood, TX). RNA and
1991). NKL is an NK cell line generously provided by M. Robertson DNA were separated by electrophoresis in agarose gels, transferred
(Dana-Farber, Boston, MA) (Robertson et al., 1996). The NK92 cell to membranes, and hybridized with the 32P-labeled probes at 658C
line was obtained from H. G. Klingemann (Gong et al., 1994). in Quickhyb (Stratagene Cloning Systems, La Jolla, CA) according
to the instructions of the manufacturer. Radioactivity was measured
Antibodies using a phosphoimager (Molecular Dynamics, Sunnyvale, CA).
The DX26 (immunoglobulin G1 [IgG1])± producing hybridoma was The chromosomal localization of the LAIR-1 gene was determined
generated by fusing the Sp2/0 myeloma cell line with splenocytes using a biotinylated LAIR-1 probe for in situ hybridization to meta-
from a BALB/c mouse immunized with a human NK clone. Antibod- phases from two normal males as described (Callen et al., 1990).
ies against DNAM-1 (DX11) (Shibuya et al., 1996) and CD69 (L78)
(Testi et al., 1989) have been described. DX10 (mouse IgG1) is a Biochemistry
CD2 MAb that was generated in our laboratory. All other MAbs To characterize biochemically the antigens recognized by DX26
were generously provided by Becton Dickinson Immunocytometry MAb, cells were labeled with 125I and antigens immunoprecipitated
Systems (San Jose, CA).
Cytotoxicity Assay
Cell lines were labeled with 51Cr andused as targets in a 4 hr radioiso-
tope release assay as described (Lanier et al., 1983). Data are ex-
pressed as the mean of triplicate cultures. Spontaneous radioiso-
tope release did not exceed 10% of maximum release as determined
by lysis of target cells with 10% Triton-X 100. The percentage spe-
cific lysis was calculated as (cpm specific 51Cr release 2 cpm spon-
taneous 51Cr release)/(cpm maximum 51Cr release 2 cpm spontane-
ous 51Cr release) 3 100.
Expression Cloning
A cDNA library was constructed from an interleukin-2±dependent
polyclonal NK line, as described (Lanier et al., 1994). cDNA cloning
by transient expression in 293T cells was performed as described
(Aruffo and Seed, 1987), with modifications (Lanier et al., 1994).
Figure 8. SHP-1 and SHP-2 Are Associated with LAIR-1 in NK Cells
upon Pervanadate StimulationRNA and DNA Analysis
cDNA was sequenced by using the dideoxy termination technique A human NK cell clone was incubated in the absence or presence
of pervanadate for 10 min at 378C. Cells were lysed and LAIR-1with a Sequenase 2.0 kit (United States Biochemical, Cleveland,
OH) and by using an automated nucleic acid sequencer (Applied proteins were immunoprecipitated with DX26 MAb. As a control,
immune precipitation with control IgG is shown. ImmunoprecipitatesBiosytems, Foster City, CA).
The 1.7 kb LAIR-1 cDNA was released from the plasmid by diges- were separated by SDS-PAGE and blotted with SHP-1 (top) and
SHP-2 (bottom) antibodies. As a control for the presence of SHP-1tion with NotII and BstxII restriction enzymes, labeled using random
hexamer primers (Feinberg and Vogelstein, 1983), and used as a and SHP-2, whole cell lysates were run on the same gel (right lanes).
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by a procedure described previously (Lanier et al., 1988a). Immuno- Feinberg, A.P., and Vogelstein, B. (1983). A technique for the radiola-
beling DNA restriction enzyme endonuclease fragments to high spe-precipitates were separated by SDS-PAGE and visualized by expo-
cific activity. Anal. Biochem. 132, 6.sure to a phosphoimager screen.
To demonstrate association of phosphatases with phosphory- Fry, A., Lanier, L.L., and Weiss, A. (1996). Phosphotyrosines in the
lated LAIR-1, NK cells were stimulated with 100 mM sodium pervan- KIR motif of NKB1 are required for negative signaling and for associ-
adate for 10 min at 378C (O'Shea et al., 1992). Cells were lysed in ation with PTP1C. J. Exp. Med. 184, 295±300.
1% NP40 in the presence of phosphatase inhibitors as described Gong, J.-H., Maki, G., and Klingemann, H.-G. (1994). Characteriza-
(Phillips et al., 1996). LAIR-1 protein was immunoprecipitated by tion of a human cell line (NK-92) with phenotypical and functional
DX26 MAb and protein G-sepharose (Pharmacia, Alameda, CA). characteristics of activated natural killer cells. Leukemia 8, 652±658.
Immunoprecipitates were separated by SDS-PAGE and transferred Hayami, K., Fukuta, D., Nishikawa, Y., Yamashita, Y., Inui, M., Oh-
to Immobilon-P membranes (Millipore, Bedford, MA). The mem- yama, Y., Hikida, M., Ohmori, H., and Takai, T. (1997). Molecular
branes were blocked and incubated with polyclonal rabbit antibod- cloning of a novel murine cell-surface glycoprotein homologous to
ies against SHP-1 and SHP-2 (C18 and C19, Santa Cruz Labora- killer cell inhibitory receptors. J. Biol. Chem. 272, 7320±7327.
tories), followed by horseradish peroxidase conjugated anti-rabbit
Karre, K., Ljunggren, H.G., Piontek, G., and Kiessling, R. (1986).immunoglobulin (Amersham, Arlington Heights, IL). Proteins were
Selective rejection of H-2-deficient lymphoma variants suggests al-detected by enhanced chemiluminescence (Supersignal Substrate,
ternative immune defense strategy. Nature 319, 675±678.Pierce, IL).
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